Certain dietary patterns are beneficial for the metabolic syndrome: Reviewing the evidence

Nutrition Research

Volumn 34, Issue 7, 2014, Pages 559-568

  Calton, Emily K ^a   James, Anthony P ^a   Pannu, Poonam K ^a   Soares, Mario J ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Asia; Diet; Dietary patterns; Human; Mediterranean diet; Metabolic syndrome

Indexed keywords

ARACHIS OIL; CALCIUM; MONOUNSATURATED FATTY ACID; OLIVE OIL; OMEGA 3 FATTY ACID; VITAMIN D;

CARBOHYDRATE INTAKE; DIET THERAPY; DIETARY APPROACH TO STOP HYPERTENSION DIET; DISEASE ASSOCIATION; FAT INTAKE; FRUIT VEGETABLE; GRAIN; HUMAN; MEDITERRANEAN DIET; MEDITERRANEAN DIET SCORE; METABOLIC SYNDROME X; NORDIC DIET; NUTRITIONAL PARAMETERS; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTAKE; RED MEAT; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; WESTERNIZED DIETARY PATTERN; WHEY; DIET; FEEDING BEHAVIOR;

DIET; FOOD HABITS; HUMANS; METABOLIC SYNDROME X;

EID: 84906791265     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.06.012     Document Type: Review

References (77)

1. Corona G., Monami M., Rastrellia G., Aversa A., Tishova Y., Saad F., et al. Testosterone and metabolic syndrome: a meta-analysis study. J Sex Med 2011, 8:272-283.
2. Cameron A.J., Magliano D.J., Zimmet P.Z., Welborn T., Shaw J.E. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract 2007, 77:471-478.
3. Ford E.S. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005, 28:1769-1778.
4. Nestel P., Lyu R., Low L.P., Sheu W.H., Nitiyanant W., Saito I., et al. Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pac J Clin Nutr 2007, 16:362-367.
5. Lorenzo C., Williams K., Hunt K., Haffner S.M. Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: The San Antonio Heart Study. Diabetes Care 2006, 29:625-630.
6. Shab-Bidar S., Hosseini-Esfahani F., Mirmiran P., Hosseinpour-Niazi S., Azizi F. Metabolic syndrome profiles, obesity measures and intake of dietary fatty acids in adults: Tehran Lipid and Glucose Study. J Hum Nutr Diet 2014, Suppl 2:98-108.
7. Ryo M., Nakamura T., Kihara S., Kumada M., Shibazaki S., Takahashi M., et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004, 68:975-981.
8. Whitehead J.P., Richards A.A., Hickman I.J., Macdonald G.A., Prins J.B. Adiponectin-a key adipokine in the metabolic syndrome. Diabetes Obes Metab 2006, 8:264-280.
9. Koh K.K., Han S.H., Quon M.J., Yeal A.J., Shin E.K. Beneficial effects of fenofibrate to improve endothelial dysfunction and raise adiponectin levels in patients with primary hypertriglyceridemia. Diabetes Care 2005, 28:1419-1424.
10. Furuhashi M., Ura N., Higashiura K., Murakami H., Tanaka M., Moniwa N., et al. Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003, 42:76-81.
11. Forsythe L.K., Wallace J.M., Livingstone M.B. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008, 21:117-133.
12. Calton E.K., Miller V.S., Soares M.J. Factors determining the risk of the metabolic syndrome: is there a central role for adiponectin?. Eur J Clin Nutr 2013, 6:485-491.
13. Jadad A., Moore R., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
14. Wang X., Li Z., Lui Y., Lv X., Yang W. Effects of pistachios on body weight in Chinese subjects with metabolic syndrome. Nutr J 2012, 11:20.
15. National Health and Medical Research Council & Department of Health and Ageing Australian dietary guidelines 2013, Australian Government, Canberra.
16. Australian Bureau of Statistics 4804.0 National Nutrition Survey 1999, ABS, Canberra.
17. Chiuve S.E., Willett W.C. The 2005 Food Guide Pyramid: an opportunity lost?. Nat Clin Pract Cardiovasc Med 2007, 4:610-620.
18. Lim S., Shin H., Song J.H., Kang S.M., Won Yoon J., Choi S.H. Increasing prevalence of metabolic syndrome in Korea: The Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011, 34:1323-1328.
19. Food and Agricultural Organization of the United Nations The state of food and agriculture in Asia and the Pacific region 2008, FAO, Bangkok.
20. Lutsey P.L., Steffen L.M., Stevens J. Dietary intake and the development of the metabolic syndrome. Circulation 2008, 117:754-761.
21. Djousse L., Padilla H., Nelson T.L., Gaziano J.M., Mukamal K.J. Diet and metabolic syndrome. Endocr Metab Immune Disord Drug Targets 2010, 10:124-137.
22. Tortosa A., Bes-Rastrollo M., Sanchez-Villegas A., Basterra-Gortari F.J., Nuñez-Cordoba J.M., Martinez-Gonzalez M.A. Mediterranean diet inversely associated with the incidence of metabolic syndrome: the SUN prospective cohort. Diabetes Care 2007, 30:2957-2959.
23. Kastorini C.M., Milionis H.J., Esposito K., Giugliano D., Goudevenos J.A., Panagiotakos D.B. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011, 57:1299-1313.
24. 1c but not fasting blood glucose compared to alternative dietary strategies: a network meta-analysis. J Hum Nutr Diet 2014, 27:280-297.
25. Rumawas M.E., Meigs J.B., Dwyer J.T., McKeown N.M., Jacques P.F. Mediterranean-style dietary pattern, reduced risk of metabolic syndrome traits, and incidence in the Framingham Offspring Cohort. Am J Clin Nutr 2009, 90:1608-1614.
26. Babio N., Bulló M., Salas-Salvadó J. Mediterranean diet and metabolic syndrome: the evidence. Public Health Nutr 2009, 12:1607-1617.
27. Esposito K., Marfella R., Ciotola M., Di Palo C., Giugliano F., Giugliano G., et al. Effect of a Mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292:1440-1446.
28. Soares M.J. The effect of olive oil on postprandial thermogenesis, fat oxidation and satiety: potential implications for weight control. Olives and olive oil in health and disease prevention 2010, 863-870. Academic Press, Oxford. V.R. Preedy, R.R. Watson (Eds.).
29. Noah A., Truswell A.S. There are many Mediterranean diets. Asia Pac J Clin Nutr 2001, 10(1):2-9.
30. Kesse-Guyot E., Ahluwalia N., Lassale C., Hercberg S., Fezeu L., Lairon D. Adherence to Mediterranean diet reduces the risk of metabolic syndrome: a 6-year prospective study. Nutr Metab Cardiovasc Dis 2012, 23:677-683.
31. Jiang R., Manson J.E., Stampfer M.J., Liu S., Willett W.C., Hu F.B. Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids. JAMA 2002, 288(20):2554-2560.
32. Rajaram S., Sabate J. Nuts, body weight and insulin resistance. Br J Nutr 2006, 96(2):S79-S86.
33. Salas-Salvado J., Fernandez-Ballart J., Ros E., Martinez-Gonzalez M.-A., Fito M., Estruch E., et al. Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008, 168(22):2449-2458.
34. Babio N., Sorli M., Bullo M., Basora J., Ibarralo-Jurado N., Fernandez-Ballart J., et al. Association between red meat consumption and metabolic syndrome in a Mediterranean population at high cardiovascular risk: cross-sectional and 1-year follow-up assessment. Nutr Metab Cardiovasc Dis 2012, 22:200-207.
35. Azadbakht L., Mirmiran P., Esmaillzadeh A., Azizi T., Azizi F. Beneficial effects of a dietary approaches to stop hypertension eating plan on features of the metabolic syndrome. Diabetes Care 2005, 28:2823-2831.
36. Adamsson V., Reumark A., Fredriksson I.-B., Hammarstrom E., Vessby B., Johansson G., et al. Effects of a healthy Nordic diet on cardiovascular risk factors in hypercholesterolaemic subjects: a randomized controlled trial (NORDIET). J Intern Med 2011, 269:150-159.
37. Adamsson V., Reumark A., Cederholm T., Vessby B., Riserus U., Johansson G. What is a healthy Nordic diet? Foods and nutrients in the NORDIET study. Food Nutr Res 2012, 56:181-189.
38. Uusitupa M., Hermansen K., Savolainen M.J., Schwab U., Kolehmainen M., Brader L., et al. Effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile and inflammation markers in metabolic syndrome-a randomized study (SYSDIET). J Intern Med 2013, 274:52-66.
39. Esmaillzadeh A., Kimiagar M., Mehrabi Y., Azadbakht L., Hu F.B., Willett W.C. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr 2006, 84(6):1489-1497.
40. Sahyoun N.R., Jacques P.F., Zhang X.L., Juan W., McKeown N.M. Whole-grain intake is inversely associated with the metabolic syndrome and mortality in older adults. Am J Clin Nutr 2006, 83(1):124-131.
41. Aronis K.N., Vamvini M.T., Chamberland J.P., Sweeney L.L., Brennan A.M., Magkos F., et al. Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study. Metabolism 2012, 61:577-582.
42. Ludwig D.S. The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 2002, 287:2414-2423.
43. Zemel M., Thompson W., Milstead A., Morris K., Campbell P. Calcium and dairy acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 2004, 12:582-590.
44. Fumeron F., Lamri A., Abi Khalil C., Jaziri R., Porchay-Baldérelli I., Lantieri O., et al. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: results from a French prospective study, Data from the Epidemiological Study on the Insulin Resistance Syndrome [DESIR]. Diabetes Care 2011, 34:813-817.
45. Crichton G.E., Bryan J., Buckley J., Murphy K.G. Dairy consumption and metabolic syndrome: a systematic review of findings and methodological issues. Obes Rev 2011, 12:e190-e201.
46. Veldhorst M., Nieuwenhuizen A.G., Hochstenbach-Waelen A., van Vught A.J., Westerterp K.R., Engelen M.P., et al. Dose-dependent satiating effect of whey relative to casein or soy. Physiol Behav 2009, 96:675-682.
47. Solah V.A., Kerr D.A., Adikara C.D., Meng X., Binns C.W., Zhu K., et al. Differences in satiety effects of alginate- and whey protein-based foods. Appetite 2010, 54:485-491.
48. Zhu K., Meng X., Kerr D., Devine A., Solah V., Binns C.W., et al. The effects of a two-year randomized, controlled trial of whey protein supplementation on bone structure, IGF-1, and urinary calcium excretion in older postmenopausal women. J Bone Miner Res 2011, 26:2298-2306.
49. Frestedt J.L., Zenk J.L., Kuskowski M., Ward L.S., Bastian E.D. A whey-protein supplement increases fat loss and spares lean muscle in obese subjects: a randomized human clinical study. Nutr Metab (Lond) 2008, 5:8.
50. Pal S., Ellis V., Dhaliwal S. Effects of whey protein isolate on body composition, lipids, insulin and glucose in overweight and obese individuals. Br J Nutr 2010, 104:716-723.
51. Zemel M., Teegarden D., Van Loan M., Schoeller A., Matkovic V., Lyle R.M., et al. Dairy-rich diets augment fat loss on an energy-restricted diet: a multicenter trial. Nutrients 2009, 1:83-100.
52. Dougkas A., Reynolds C.K., Givens I.D., Elwood P.C., Minihane A.M. Associations between dairy consumption and body weight: a review of the evidence and underlying mechanisms. Nutr Res Rev 2011, 15:1-24.
53. Soares M.J., Muhardi L., Kurpad A.V., Chan She Ping-Delfos W.L., Piers L.S. Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev 2012, 13:592-605.
54. Onakpoya I.J., Perry R., Zhang J., Ernst E. Efficacy of calcium supplementation for management of overweight and obesity: systematic review of randomized clinical trials. Nutr Rev 2011, 69:335-343.
55. Forouhi N.G., Luan J., Cooper A., Boucher B.J., Wareham N.J. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57:2619-2625.
56. Fung G.J., Steffen L.M., Zhou X., Harnack L., Tang W., Lutsey P.L., et al. Vitamin D intake is inversely related to risk of developing metabolic syndrome in African American and white men and women over 20y: the Coronary Artery Risk Development in Young Adults study. Am J Clin Nutr 2012, 96:24-29.
57. Boucher B.J. Is vitamin D status relevant to metabolic syndrome?. Dermatoendocrinology 2012, 4:212-224.
58. Soares M.J., Chan She Ping-Delfos W., Sherriff J.L., Nezhad D.H., Cummings N.K., Zhao Y. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect. Eur J Clin Nutr 2011, 65:1348-1352.
59. Zemel M.B., Sun X., Sobhani T., Wilson B. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am J Clin Nutr 2010, 91:16-22.
60. Lara-Castro C., Fu Y., Chung B.H., Garvey W.T. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007, 18:263-270.
61. Ruige J.B., Ballaux D.B., Funahashi T., Mertens I.L., Matsuzawa Y., Van Gaal L.F. Resting metabolic rate is an important predictor of serum adiponectin concentrations: potential implications for obesity-related disorders. Am J Clin Nutr 2005, 82:21-25.
62. Vaidya A., Forman J.P., Underwood P.C., Hopkins P.N., Williams G.H., Pojoga L.H., et al. The influence of body mass index and renin-angiotensin-aldosterone system activity on the relationship between 25-hydroxyvitamin D and adiponectin in Caucasian men. Eur J Endocrinol 2011, 164:995-1002.
63. Paniagua J.A., Perez-Martinez P., Gjelstad I.M., Tierney A.C., Delgado-Lista J., Defoort C., et al. A low-fat high-carbohydrate diet supplemented with long-chain n-3 PUFA reduces the risk of the metabolic syndrome. Atherosclerosis 2011, 218:443-450.
64. Te Morenga L.A., Levers M.T., Williams S.M., Brown R.C., Mann J. Comparison of high protein and higher fiber weight-loss diets in women with risk factors for the metabolic syndrome: a randomized trial. Nutr J 2011, 10:40. 10.1186/1475-2891-10-40.
65. Shaw D.I., Tierney A.C., McCarthy S., Upritchard J., Vermunt S., Gulseth H.L., et al. LIPGENE food-exchange model for alteration of dietary fat quantity and quality in free-living participants from eight European countries. Br J Nutr 2008, 101:750-759.
66. Baik I., Abbott R.D., Curb D., Shin C. Intake of fish and n-3 fatty acids and future risk of metabolic syndrome. J Am Diet Assoc 2010, 110:1018-1026.
67. Vanhala M., Saltevo J., Soininen P., Kautiainen H., Kangas A.J., Ala-Korpela M., et al. Serum omega-6 polyunsaturated fatty acids and the metabolic syndrome: a longitudinal population-based cohort study. Am J Epidemiol 2012, 176(3):253-260.
68. Gillingham L.G., Harris-Janz S., Jones P.J.H. Dietary monounsaturated fatty acids are protective against metabolic syndrome and cardiovascular disease risk factors. Lipids 2011, 46:209-228.
69. Sundstrom J., Lind L., Vessby B., Andren B., Aro A., Lithell H.O. Dyslipidemia and an unfavorable fatty acid profile predict left ventricular hypertrophy 20 years later. Circulation 2001, 103:836-841.
70. Milte C.M., Coates A.M., Buckley J.D., Hill A.M., Howe P.R.C. Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. Br J Nutr 2008, 99:1083-1088.
71. Mori T.A., Watts G.F., Burke V., Hilme E., Puddey I.B., Lawrence J. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. J Am Heart Assoc 2000, 102:1264-1269.
72. Sanders T.A.B., Gleason K., Griffin B., Miller G.J. Influence of an algal triacylglycerol containing docosahexaenoic acid (22:6n-3) and docosapentaenoic acid (22:5n-6) on cardiovascular risk factors in healthy men and women. Br J Nutr 2006, 95:525-531.
73. Theobald H.E., Chowiencyzk P.J., Whittall R., Humphries S.E., Sanders T.A.B. LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women. Am J Clin Nutr 2004, 79:558-563.
74. Higgins S., Carroll Y.L., McCarthy S.N., Corridan B.M., Roche H.M., Wallace J.M.W., et al. Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids. Br J Nutr 2001, 85:23-31.
75. Poudyal H., Panchal S.K., Diwan V., Brown L. Omega-3 fatty acids and metabolic syndrome: effects and emerging mechanisms of action. Prog Lipid Res 2011, 50:372-387.
76. Anderson B.M., Ma D.W.L. Are all n-3 polyunsaturated fatty acids created equal?. Lipids Health Dis 2009, 8:33-53.
77. Cornier M.A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., et al. The metabolic syndrome. Endocr Rev 2008, 29:777-822.